# Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients

> **NCT05676593** · NA · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 40 (estimated)

## Conditions studied

- Endocrinology
- Type 2 Diabetes

## Interventions

- **DEVICE:** Freestyle Libre 2
- **OTHER:** Therapeutic education

## Key facts

- **NCT ID:** NCT05676593
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-03
- **Primary completion:** 2024-11-03
- **Final completion:** 2024-12-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05676593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05676593, "Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05676593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*